Investing

uniQure : QURE

QURE

Stock Data

$19.13

$0.82 (4.11%)

Asset Type

N/A

Exchange

N/A

Currency

N/A

Country

N/A

Sector

N/A

Industry

N/A

uniQure N.V., based in Amsterdam, specializes in pioneering gene therapies for rare and severe diseases. Its notable product, HEMGENIX, targets hemophilia B and has successfully completed a crucial Phase III trial. The company is also advancing treatments for Huntington’s disease, ALS, temporal lobe epilepsy, Fabry disease, Alzheimer’s, and Parkinson’s through various stages of clinical and preclinical development. Founded in 1998, uniQure is at the forefront of genetic medicine, aiming to transform the lives of patients with groundbreaking treatments.

All uniQure Articles

11 Articles

Joel South | Mar 9, 2026 at 11:17 AM EDT

uniQure, Syndax and Erasca Are Drawing Analyst Interest Ahead of Key Drug Catalysts

Wall Street is turning constructive on three clinical-stage biotechs simultaneously, each sitting at the edge of a binary catalyst. The…

Lee Jackson | Mar 3, 2026 at 8:00 AM EST

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Block, CrowdStrike, Fortinet, MongoDB, Mosaic, Palo Alto Networks, Unity Software, and More

Pre-Market Stock Futures: Futures are down big as oil shoots higher on Tuesday.  After a big early morning sell-off on…

Lee Jackson | Jan 3, 2023 at 8:45 AM EST

Tuesday’s Top Analyst Upgrades and Downgrades: Ally Financial, Apple, Block, DR Horton, EOG, Ford, Micron, PayPal, Pfizer and More

Tuesday's top analyst upgrades and downgrades included Ally Financial, Apple, Ardelyx, Block, DocuSign, D.R. Horton, Enovix, EOG Resources, Ford, Futu,…

Lee Jackson | Mar 17, 2022 at 8:57 AM EDT

Thursday’s Top Analyst Upgrades and Downgrades: Adobe, American Airlines, Coupa Software, Disney, Host Hotels, Nio, Roblox, SentinelOne and More

Thursday's top analyst upgrades and downgrades included Adobe, American Airlines, Coupa Software, Delta Air Lines, Host Hotels & Resorts, Nio,…

Lee Jackson | Jun 15, 2021 at 1:02 PM EDT

Alliance Data, Cimarex Energy, Myriad Genetics, Nestle and More Tuesday Afternoon Analyst Research Calls

Alliance Data, Cimarex Energy, Myriad Genetics and Nestle were among Tuesday afternoon's analyst upgrades and downgrades.

Lee Jackson | May 21, 2021 at 8:48 AM EDT

Friday’s Top Analyst Upgrades and Downgrades: AT&T, Cisco, Dish Network, Energy Transfer, Splunk, Virgin Galactic and More

Friday's top analyst upgrades and downgrades included AT&T, Cisco Systems, Datadog, Dish Network, Energy Transfer, Pioneer Natural Resources, Splunk and…

Lee Jackson | Apr 1, 2021 at 8:48 AM EDT

Top Analyst Upgrades and Downgrades: Carnival, Dow, Goldman Sachs, Micron, Netflix, Oracle, Snap, Spotify, Twitter and More

Thursday's top analyst upgrades and downgrades included Carnival, Dow, Goldman Sachs, Micron Technology, Netflix, Oracle, Snap, Spotify and Twitter.

Lee Jackson | Dec 21, 2020 at 8:15 AM EST

5 Top Biotech Stocks to Buy for 2021 With Massive Upside Potential

A new Stifel research report includes the firm's biotech stock picks for 2021. These five have the biggest upside to…

Lee Jackson | Dec 3, 2020 at 7:59 AM EST

Raymond James Top Health Care Picks Crushing S&P 500: 4 Stocks to Buy Now

Health care has been a top performer this year, and there is every reason to believe that performance will carry…

Jon C. Ogg | Dec 3, 2019 at 9:00 AM EST

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Beyond Meat, CommScope, Enphase, Nabors, Netflix, Nike, Roku, Tesla, Uber, Williams Companies and More

Tuesday's top analyst upgrades, downgrades and initiations included Alphabet, Amazon.com, Beyond Meat, CommScope, Enphase Energy, Nabors Industries, Netflix, Nike, Roku,…

Jon C. Ogg | Sep 4, 2019 at 5:11 PM EDT

8 Secondary Stock Offerings Total Up to $3 Billion That Has to Be Sold

Here are eight secondary offerings that have been filed with a grand tally of about $3 billion combined.